3,211 Shares in Steris PLC (STE) Purchased by GSA Capital Partners LLP
GSA Capital Partners LLP purchased a new position in Steris PLC (NYSE:STE) in the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 3,211 shares of the medical equipment provider’s stock, valued at approximately $284,000.
Several other large investors also recently modified their holdings of STE. Schwab Charles Investment Management Inc. lifted its stake in shares of Steris by 31.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 325,685 shares of the medical equipment provider’s stock worth $26,544,000 after acquiring an additional 77,516 shares during the period. First Trust Advisors LP lifted its stake in shares of Steris by 84.6% in the 2nd quarter. First Trust Advisors LP now owns 15,865 shares of the medical equipment provider’s stock worth $1,293,000 after acquiring an additional 7,272 shares during the period. State Board of Administration of Florida Retirement System acquired a new stake in shares of Steris in the 2nd quarter worth approximately $1,292,000. Neuberger Berman Group LLC raised its holdings in shares of Steris by 7.4% in the 2nd quarter. Neuberger Berman Group LLC now owns 8,197 shares of the medical equipment provider’s stock worth $668,000 after purchasing an additional 562 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Steris by 10.5% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,276 shares of the medical equipment provider’s stock worth $267,000 after purchasing an additional 311 shares in the last quarter. 89.40% of the stock is owned by institutional investors.
In other news, insider Michael J. Tokich sold 11,000 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $92.00, for a total transaction of $1,012,000.00. Following the sale, the insider now owns 58,588 shares in the company, valued at $5,390,096. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP John Adam Zangerle sold 3,650 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $88.00, for a total transaction of $321,200.00. The disclosure for this sale can be found here. 2.55% of the stock is owned by insiders.
Shares of Steris PLC (NYSE:STE) opened at $89.96 on Wednesday. The company has a quick ratio of 2.18, a current ratio of 2.80 and a debt-to-equity ratio of 0.48. Steris PLC has a fifty-two week low of $65.26 and a fifty-two week high of $93.39. The company has a market cap of $7,670.00, a P/E ratio of 53.87 and a beta of 1.27.
Steris (NYSE:STE) last released its earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.01). Steris had a return on equity of 11.49% and a net margin of 5.59%. The business had revenue of $634.20 million during the quarter, compared to the consensus estimate of $629.02 million. During the same quarter in the previous year, the firm earned $0.89 earnings per share. The firm’s revenue for the quarter was down 1.9% compared to the same quarter last year. analysts predict that Steris PLC will post 4.06 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 20th. Investors of record on Wednesday, November 22nd were issued a $0.31 dividend. The ex-dividend date of this dividend was Tuesday, November 21st. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.38%. Steris’s payout ratio is currently 74.25%.
A number of analysts recently commented on the stock. Raymond James Financial reiterated a “market perform” rating and issued a $100.00 target price on shares of Steris in a report on Wednesday, January 3rd. Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $101.00 target price on the stock in a report on Monday, October 9th. KeyCorp reiterated a “buy” rating and issued a $91.00 target price on shares of Steris in a report on Tuesday, October 17th. Finally, TD Securities boosted their target price on shares of Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a report on Thursday, November 9th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Steris currently has an average rating of “Buy” and an average price target of $79.50.
COPYRIGHT VIOLATION NOTICE: “3,211 Shares in Steris PLC (STE) Purchased by GSA Capital Partners LLP” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/3211-shares-in-steris-plc-ste-purchased-by-gsa-capital-partners-llp/1800989.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with Analyst Ratings Network's FREE daily email newsletter.